Related Experiment Video
Updated: Oct 16, 2025
15:41
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
Published on: October 15, 2013
15.1K
Microfluidic Single-Cell Proteomics Assay Chip: Lung Cancer Cell Line Case Study.
Yugyung Jung1, Minkook Son1, Yu Ri Nam1,2
1Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Micromachines
|October 23, 2021
Summary
This study introduces a microfluidic chip for single-cell proteomics, analyzing cancer cell heterogeneity to improve chemotherapy drug selection. This technology aids in developing patient-customized cancer therapies by revealing protein correlations.
Area of Science:
- Biotechnology
- Cancer Research
- Proteomics
Background:
- Cancer cell heterogeneity drives chemotherapy resistance and recurrence.
- Single-cell analysis is crucial for understanding cancer cell variability.
- Existing bulk analysis methods can mask important cellular differences.
Purpose of the Study:
- To develop a microfluidic chip for single-cell proteomics analysis.
- To investigate cancer cell heterogeneity and protein correlations.
- To identify effective anti-cancer drug combinations for personalized therapy.
Main Methods:
- A microfluidic chip with 1376 microchambers for single-cell manipulation.
- Micropumps for rapid single-cell lysis.
- Barcode immunosensors for detecting nine secretory and intracellular proteins.
Main Results:
- Evaluated single-cell proteomics of a lung cancer cell line.
- Revealed protein secretion and heterogeneity changes in response to anti-cancer drugs.
- Demonstrated a new method for selecting optimal anti-cancer drug combinations.
Conclusions:
- The developed microfluidic chip enables detailed single-cell proteomics.
- This platform can reveal cancer cell heterogeneity and protein correlations.
- The findings suggest potential for patient-customized cancer therapies.
